A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis
PHASE4CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
February 28, 2007
Study Completion Date
July 31, 2007
Conditions
Secondary Hyperparathyroidism
Interventions
DRUG
Hectorol (doxercalciferol injection)
DRUG
Zemplar (Paricalcitol injection)
Trial Locations (1)
Unknown
Minneapolis
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT00454350 - A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis | Biotech Hunter | Biotech Hunter